[The lacto-complex in the therapy of gastroesophageal reflux. Clinical and endoscopic evaluation].
The activity and therapeutic efficacy of a micro-dispersed lacto-complex in the management of patients with gastro-oesophageal regurgitation were evaluated in terms of the clinical and endoscopic data observed before and 40-60 days after treatment. The results were more than satisfactory. Endoscopic assessment was also made of the stratification and residence time of the preparation in the normal and pathological oesophageal and gastric mucosa. There was a significant increase in residence times in the case of lesion of the mucosae themselves.
D000863:Antacids / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004942:Esophagitis, Peptic / Q000188:drug therapy; D004945:Esophagoscopy; D005764:Gastroesophageal Reflux / Q000188:drug therapy*; D006356:Heartburn / Q000188:drug therapy; D006551:Hernia, Hiatal / Q000150:complications; D006801:Humans; D007773:Lactates / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000188:drug therapy
D000863:Antacids; D000893:Anti-Inflammatory Agents; D007773:Lactates
Il lattocomplesso nella terapia del reflusso gastroesofageo. Valutazione clinica ed endoscopica